Results 221 to 230 of about 48,696 (305)

Extended use of dabigatran no better than warfarin for high‐risk patients after VTE [PDF]

, 2013

openalex   +1 more source

Dabigatran und Blutungsrisiko

Praxis, 2015
openaire   +2 more sources

Risk of bleeding with dentoalveolar surgery in patients taking direct oral anticoagulants or vitamin K antagonists: A systematic review and meta-analysis. [PDF]

Jpn Dent Sci Rev
Dou K, Shi Y, Yang B, Zhao Z.
europepmc   +1 more source

Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches. [PDF]

J Cell Biochem
Barreto EM, Pereira GRC, Arêas IS, Fortes JM, Domingos ADS, Cabral LM, Rodrigues CR, de Souza AMT, Abrahim-Vieira BA.   +8 more
europepmc   +1 more source

Comparative risk of osteoporotic fractures with direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients: a systematic review. [PDF]

Int J Burns Trauma
Mojahedi A, Singh A, Sadeghian A, Chen O.   +3 more
europepmc   +1 more source

A dabigatran iv. antidótumának, az idarucizumabnak első hazai alkalmazásai sürgős műtétek esetén = The first uses of iv. idarucizumab for dabigatran reversal in cases of urgent surgeries in Hungary [PDF]

, 2017
Barabás, Éva, Bencsik, Gábor, Bodócs, Ildikó, Borbola, József, Driesz, Lajos, Hajdú, Attila, Herr, György, Pál, László, Szántó, Zoltán   +8 more
core   +1 more source

The Use of Direct Oral Anticoagulants (DOACs) in the Geriatric Population-How to Overcome the Challenges of Geriatric Syndromes. [PDF]

J Clin Med
Badescu MC, Popescu D, Gosav EM, Costache AD, Cosău DE, Chetran A, Duca ȘT, Cucută S, Șerban IL, Costache Enache II, Rezus C.   +10 more
europepmc   +1 more source

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model [PDF]

, 2014
Oliver Grottke, Joanne van Ryn, Henri M.H. Spronk, Rolf Rossaint   +3 more
openalex   +1 more source

Osmotic laxatives do not alter dabigatran plasma concentration in healthy volunteers - a randomized, controlled, cross-over trial. [PDF]

Front Pharmacol
Weiss-Tessbach M, Dizdarevic AM, Kupis A, Bischof T, Firbas C, Quehenberger P, Derhaschnig U, Frimmel M, Jilma B, Schoergenhofer C.   +9 more
europepmc   +1 more source

Editorial Comment: Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study. [PDF]

Acta Cardiol Sin
Liu CM, Chao TF.
europepmc   +1 more source